Search Results - cd254

Bevacizumab Biosimilar, Anti-human VEGF Antibody | C001P

Bevacizumab Biosimilar, Human VEGF Monoclonal Antibody. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human...

Bevacizumab Biosimilar, N297A Mutant C001P.NA Syd Labs

Bevacizumab Biosimilar, N297A Mutant | C001P.NA

Bevacizumab Biosimilar, N297A Mutant. Bevacizumab biosimilar CHO stable cell line is available for licensing to manufacture the bevacizumab biosimilar protein.The research grade bevacizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...

Recombinant Human RANKL Protein: BP000050-GD13 Syd Labs

Recombinant Human RANKL Protein

Syd Labs Recombinant Human RANKL Protein BP000050-GD13, The activity of the RANKL protein (RANK ligand, TNFSF11, TRANCE, OPGL, CD254) is calculated by its ability to induce osteoclast differentiation on RAW 264.7 mouse macrophages. The ED50...